| LDR | | 01660nmm uu200421 4500 |
| 001 | | 000000332162 |
| 005 | | 20240805170145 |
| 008 | | 181129s2018 |||||||||||||||||c||eng d |
| 020 | |
▼a 9780438265035 |
| 035 | |
▼a (MiAaPQ)AAI10956680 |
| 035 | |
▼a (MiAaPQ)0799vireo:920Jayawardena |
| 040 | |
▼a MiAaPQ
▼c MiAaPQ
▼d 248032 |
| 082 | 0 |
▼a 615 |
| 100 | 1 |
▼a Jayawardena, Dulari. |
| 245 | 10 |
▼a Vasoactive Intestinal Peptide Nanomedicine for the Treatment of Inflammatory Bowel Disease. |
| 260 | |
▼a [S.l.] :
▼b University of Illinois at Chicago.,
▼c 2018 |
| 260 | 1 |
▼a Ann Arbor :
▼b ProQuest Dissertations & Theses,
▼c 2018 |
| 300 | |
▼a 231 p. |
| 500 | |
▼a Source: Dissertation Abstracts International, Volume: 79-12(E), Section: B. |
| 500 | |
▼a Advisers: Hayat Onyuksel |
| 502 | 1 |
▼a Thesis (Ph.D.)--University of Illinois at Chicago, 2018. |
| 520 | |
▼a Vasoactive intestinal peptide (VIP) is an endogenous neuropeptide with a wide array of immunomodulatory properties. VIP has shown beneficial effects in managing multiple inflammatory disorders, including inflammatory bowel disease (IBD). IBD inc |
| 590 | |
▼a School code: 0799. |
| 650 | 4 |
▼a Pharmacology. |
| 650 | 4 |
▼a Molecular biology. |
| 650 | 4 |
▼a Pharmaceutical sciences. |
| 690 | |
▼a 0419 |
| 690 | |
▼a 0307 |
| 690 | |
▼a 0572 |
| 710 | 20 |
▼a University of Illinois at Chicago.
▼b Biopharmaceutical Sciences. |
| 773 | 0 |
▼t Dissertation Abstracts International
▼g 79-12B(E). |
| 773 | |
▼t Dissertation Abstract International |
| 790 | |
▼a 0799 |
| 791 | |
▼a Ph.D. |
| 792 | |
▼a 2018 |
| 793 | |
▼a English |
| 856 | 40 |
▼u http://www.riss.kr/pdu/ddodLink.do?id=T15001227
▼n KERIS |
| 980 | |
▼a 201812
▼f 2019 |
| 990 | |
▼a 관리자 |